Oral SAHA (Suberoylanilide Hydroxamic Acid) in Advanced Cutaneous T-cell Lymphoma (0683-001)
Clinical trial NCT00091559 · COMPLETED
Trial details
- NCT number
- NCT00091559
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-02-03
- Primary completion
- 2005-11-23
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.